Citing the need for animal vaccine research development, DOST said the financial assistance granted to BioAssets Corporation will be used to acquire the latest technologies that will help establish a point-of-need animal health diagnostic system.
“With great potential, Bio Assets Corporation through the BIST program may be able to expand the function of vaccine R&D and address the ASF,” said DOST Secretary Fortunato T. de la Peña. “The BIST program strengthens the capabilities of our local companies and enables them to overcome barriers through the outputs of R&D,” Guevara added.